Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CVR Medical Corp
CRRVF
Primary Symbol:
V.CVM.H
Healthcare
Medical Devices
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool...
, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CVM.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
Roguey1
X
View Profile
View Bullboard History
Post by
Roguey1
on Dec 05, 2022 6:58pm
NEX
Sorry! Meant NEX.
(0)
•••
Roguey1
X
View Profile
View Bullboard History
Post by
Roguey1
on Dec 05, 2022 6:56pm
Nex
Excuse my ignorance, but can we access the NET board? thx in advance.
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2%
posted May 28, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur's first international distribution agreement is over a three-year term with a company specializing in the sale of radiology products in Latin America. This initial agreement grants the distributor marketing and sales rights in two countries, for SmoothX 2%, a contrast medium for use in abdominal Computed Tomography (CT) diagnostic examinations. ...read more
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Post by
Abovenbeyond
on Dec 05, 2022 5:05pm
Here we go
Up 587% today
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 01, 2022 7:18pm
New Press Release - CVR Medical Corp. Announces Completion of 2022 3rd Quarter Financial Statement
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2022) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US based healthcare company in the medical device market is pleased to announce the completion and filing of its 2022 Q3...
read article.
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Dec 01, 2022 12:00pm
RE:RE:RE:RE:RE:NEX listing
?
(393)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Nov 14, 2022 3:28pm
RE:RE:RE:RE:RE:NEX listing
Who would give cash to these crooks? I would have thought someone would have bought this company by now if the CSS is as good as it's touted to be. Total tragedy!!
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Nov 13, 2022 12:47pm
RE:RE:RE:RE:NEX listing
Hopefully they will be able to do that, the main problem will be getting the cash to psy for the trials
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Nov 12, 2022 8:04pm
RE:RE:RE:NEX listing
Weren't they just like 10 trials short from getting fda approval? Why submit to the fda and be a few trials short of required? Can't they just get what they need and submit again.?
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Nov 12, 2022 7:42pm
RE:RE:NEX listing
CVRs listing details on the NEX, hardly surprising they were kicked of the TSX V the details are so far out of date it shows they clearly didn't give a toss about the listing and just used it as a
...more
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Nov 12, 2022 1:41pm
RE:NEX listing
What's this?
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Post by
Looneytunes
on Nov 12, 2022 3:35am
NEX listing
https://apps.tmx.com/TMX/HttpController?GetPage=NEXQuotesViewPage&IsJ2Market=Yes&RowNumber=1&SelectedSymbol=CVM.H&DetailedView=DetailedCompanyInformation&QuoteSymbol_1=CVM&
...more
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Nov 10, 2022 7:39pm
RE:RE:RE:RE:This is what happened
Glad you have some info to share. Thanks
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Nov 10, 2022 5:57pm
RE:RE:RE:This is what happened
The way I'm reading it is that all we can do is wait to see whether Blunden and co can actually get the CSS through its trials and submitted to the FDA. Even though we can't trade them, our
...more
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Nov 09, 2022 5:02pm
RE:RE:This is what happened
So now what?
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Nov 09, 2022 4:23pm
RE:This is what happened
Wow
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024